Benzinga's Top Upgrades, Downgrades For May 1, 2020

Upgrades

  • Piper Sandler changed the rating for Lakeland Bancorp Inc LBAI from Neutral to Overweight. For the first quarter, Lakeland Bancorp had an EPS of $0.24, compared to year-ago quarter EPS of $0.35. The stock has a 52-week-high of $17.63 and a 52-week-low of $8.31. Lakeland Bancorp's stock last closed at $11.19 per share.
  • KeyBanc upgraded the stock for Wolverine World Wide Inc WWW from Sector Weight to Overweight. In the first quarter, Wolverine World Wide showed an EPS of $0.28, compared to $0.49 from the year-ago quarter. The stock has a 52-week-high of $37.58 and a 52-week-low of $12.19. Wolverine World Wide's stock last closed at $20.85 per share.
  • Janney Capital changed the rating for California Water Service Group CWT from Neutral to Buy. California Water Service earned ($0.42) in the first quarter, compared to ($0.16) in the year-ago quarter. The stock has a 52-week-high of $57.48 and a 52-week-low of $39.74. California Water Service's stock last closed at $45.15 per share.
  • For Seattle Genetics Inc SGEN, Guggenheim upgraded the stock from Neutral to Buy. For the first quarter, Seattle Genetics had an EPS of ($0.98), compared to year-ago quarter EPS of ($0.08). The stock has a 52-week-high of $150.00 and a 52-week-low of $62.90. Seattle Genetics's stock last closed at $137.23 per share.

 

Downgrades

  • BTIG downgraded the stock for On Deck Capital Inc ONDK from Buy to Neutral. In the first quarter, On Deck Capital showed an EPS of ($0.92), compared to $0.10 from the year-ago quarter. The stock has a 52-week-high of $5.69 and a 52-week-low of $0.54. On Deck Capital's stock last closed at $1.20 per share.
  • For Autodesk Inc ADSK, Bernstein downgraded the stock from Market Perform to Underperform. Autodesk earned $0.92 in the fourth quarter, compared to $0.46 in the year-ago quarter. The stock has a 52-week-high of $211.58 and a 52-week-low of $125.38. Autodesk's stock last closed at $187.13 per share.
  • Credit Suisse changed the rating for Cabot Oil & Gas Corp COG from Outperform to Neutral. In the first quarter, Cabot Oil & Gas showed an EPS of $0.14, compared to $0.73 from the year-ago quarter. The stock has a 52-week-high of $27.41 and a 52-week-low of $13.06. Cabot Oil & Gas's stock last closed at $20.79 per share.
  • For Cerner Corp CERN, SunTrust Robinson Humphrey downgraded the stock from Buy to Hold. For the first quarter, Cerner had an EPS of $0.71, compared to year-ago quarter EPS of $0.61. The stock has a 52-week-high of $80.90 and a 52-week-low of $53.08. Cerner's stock last closed at $69.39 per share.
  • For Dow Inc DOW, Citigroup downgraded the stock from Buy to Neutral. In the first quarter, Dow showed an EPS of $0.59, compared to $0.84 from the year-ago quarter. The stock has a 52-week-high of $57.48 and a 52-week-low of $21.95. Dow's stock last closed at $36.70 per share.
  • Loop Capital changed the rating for Hub Group Inc HUBG from Buy to Hold. For the first quarter, Hub Group had an EPS of $0.47, compared to year-ago quarter EPS of $0.71. The stock has a 52-week-high of $60.41 and a 52-week-low of $36.51. Hub Group's stock last closed at $48.11 per share.
  • For Textron Inc TXT, JP Morgan downgraded the stock from Overweight to Neutral. For the first quarter, Textron had an EPS of $0.35, compared to year-ago quarter EPS of $0.76. The stock has a 52-week-high of $54.24 and a 52-week-low of $20.26. Textron's stock last closed at $26.79 per share.
  • Wells Fargo downgraded the stock for Beyond Meat Inc BYND from Equal-Weight to Underweight. Beyond Meat earned ($0.01) in the fourth quarter. The stock has a 52-week-high of $239.71 and a 52-week-low of $45.00. Beyond Meat's stock last closed at $98.99 per share.
  • MKM Partners downgraded the stock for Willis Towers Watson PLC WLTW from Buy to Neutral. In the first quarter, Willis Towers Watson showed an EPS of $3.34, compared to $2.98 from the year-ago quarter. The stock has a 52-week-high of $220.97 and a 52-week-low of $143.34. Willis Towers Watson's stock last closed at $178.29 per share.
  • Benchmark downgraded the stock for Huron Consulting Group Inc HURN from Buy to Hold. For the first quarter, Huron Consulting Group had an EPS of $0.44, compared to year-ago quarter EPS of $0.40. The stock has a 52-week-high of $70.91 and a 52-week-low of $35.15. Huron Consulting Group's stock last closed at $56.04 per share.
  • For EMCOR Group Inc EME, DA Davidson downgraded the stock from Buy to Neutral. For the first quarter, EMCOR Gr had an EPS of $1.35, compared to year-ago quarter EPS of $1.28. The stock has a 52-week-high of $93.54 and a 52-week-low of $41.85. EMCOR Gr's stock last closed at $63.51 per share.
  • For Gilead Sciences Inc GILD, JP Morgan downgraded the stock from Overweight to Neutral. In the first quarter, Gilead Sciences showed an EPS of $1.68, compared to $1.76 from the year-ago quarter. The stock has a 52-week-high of $85.97 and a 52-week-low of $60.89. Gilead Sciences's stock last closed at $84.00 per share.

 

Initiations

  • SunTrust Robinson Humphrey initiated coverage on Air Transport Services Group Inc ATSG with a Buy rating. The price target for Air Transport Services Gr is set at $27.00. In the fourth quarter, Air Transport Services Gr showed an EPS of $0.56, compared to $0.36 from the year-ago quarter. The stock has a 52-week-high of $25.60 and a 52-week-low of $13.20. Air Transport Services Gr's stock last closed at $20.24 per share.
  • With a rating of Buy, BTIG initiated coverage on Axcella Health Inc AXLA. The price target is set at $10.00 for Axcella Health. Interestingly, in the fourth quarter, Axcella Health's EPS was ($0.68). The stock has a 52-week-high of $15.99 and a 52-week-low of $2.25. Axcella Health's stock last closed at $4.66 per share.
  • BTIG initiated coverage on Viking Therapeutics Inc VKTX with a Buy rating. The price target for Viking Therapeutics is set at $9.00. For the first quarter, Viking Therapeutics had an EPS of ($0.13), compared to year-ago quarter EPS of ($0.07). The stock has a 52-week-high of $8.92 and a 52-week-low of $3.26. Viking Therapeutics's stock last closed at $5.76 per share.
  • Janney Capital initiated coverage on Y-mAbs Therapeutics Inc YMAB with a Buy rating. Y-mAbs Therapeutics earned ($0.61) in the fourth quarter, compared to ($0.42) in the year-ago quarter. The stock has a 52-week-high of $36.55 and a 52-week-low of $14.16. Y-mAbs Therapeutics's stock last closed at $33.58 per share.
  • Cowen & Co. initiated coverage on FibroGen Inc FGEN with a Market Perform rating. The price target for FibroGen is set at $40.00. FibroGen earned ($1.12) in the fourth quarter, compared to $0.23 in the year-ago quarter. The stock has a 52-week-high of $49.29 and a 52-week-low of $22.65. FibroGen's stock last closed at $36.89 per share.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesDowngradesInitiationIntraday UpdateAnalyst RatingsInitiationstop upgrades
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!